An Open-label Study of Intravenous Immunoglobulin (5%) for the Treatment of Primary Immune Thrombocytopenia
Conditions
Primary Immune Thrombocytopenia (ITP)
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Hacettepe University Faculty of Medicine, Ankara, Altındağ, Turkey (Türkiye)
Contact: Study coordinator (Prof. Dr. Salih Aksu)Contact: Principal Investigator (Prof. Dr. Salih Aksu)İnönü University Turgut Ozal Medical Center Training and Research Hospital, Malatya, Battalgazi, Turkey (Türkiye)
Contact: Principal Investigator (Prof. Dr. Emin Kaya)İstanbul University, Istanbul Faculty of Medicine, Istanbul, Fatih, Turkey (Türkiye)
Contact: Principal Investigator (Prof. Dr. Sevgi Beşışık)Erciyes University Hematology Hospital, Kayseri, Melikgazi, Turkey (Türkiye)
Contact: Principal Investigator (Neslihan Mandaci Sanli)VM Medical Park Mersin, Mersin, Mezitli, Turkey (Türkiye)
Contact: Principal Investigator (Prof. Dr. Anıl Tombak)Antalya Training and Research Hospital, Antalya, Muratpaşa, Turkey (Türkiye)
Contact: Study coordinator (Assoc. Prof. Dr. Volkan Karakuş) · dr_v_karakus@yahoo.com · +90 505 765 67 78Contact: Principal Investigator (Assoc. Prof. Dr. Volkan Karakuş)Dr. Abdurrahman Yurtaslan Ankara Onkoloji Eğitim ve Araştırma Hastanesi, Ankara, Yenimahalle, Turkey (Türkiye)
Contact: Principal Investigator (Prof. Dr. Mehmet Sinan Dal)Adana City Education and Research Hospital, Hematology Department, Adana, Yüreğir, Turkey (Türkiye)
Contact: Study coordinator (Assoc. Prof. Dr. Didar Yanardağ Açık) · didaryanardag@gmail.com · +90 532 157 76 56Contact: Principal Investigator (Assoc. Prof. Dr. Didar Yanardağ Açık)Gaziantep University Şahinbey Training and Research Hospital, Gaziantep, Şehitkamil, Turkey (Türkiye)
Contact: Principal Investigator (Prof. Dr. Vahap Okan)